Atlas Trials

A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants

Clinical trial NCT02034162 · COMPLETED

Trial details

NCT number
NCT02034162
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Helminth Infections
Start date
2014-12-01
Primary completion
2015-09-01
Enrollment
295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.